Diisopropylethylamine → tert-Butyl 5-(9-(pyridin-4-yl)-3,9-diazaspiro[5.5]undecane-3-carbonyl)isoindoline-2-carboxylate

HRID 1808379ノート

反応式

HRID 1808379 の反応式
[C:1]([O:5][C:6]([N:8]1[CH2:16][C:15]2[C:10](=[CH:11][CH:12]=[C:13]([C:17]([OH:19])=O)[CH:14]=2)[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].F[B-](F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.O.ON1C2C=CC=CC=2N=N1.Cl.Cl.[N:55]1[CH:60]=[CH:59][C:58]([N:61]2[CH2:66][CH2:65][C:64]3([CH2:71][CH2:70][NH:69][CH2:68][CH2:67]3)[CH2:63][CH2:62]2)=[CH:57][CH:56]=1.C(N(C(C)C)CC)(C)C>O1CCCC1>[N:55]1[CH:56]=[CH:57][C:58]([N:61]2[CH2:66][CH2:65][C:64]3([CH2:67][CH2:68][N:69]([C:17]([C:13]4[CH:14]=[C:15]5[C:10](=[CH:11][CH:12]=4)[CH2:9][N:8]([C:6]([O:5][C:1]([CH3:2])([CH3:3])[CH3:4])=[O:7])[CH2:16]5)=[O:19])[CH2:70][CH2:71]3)[CH2:63][CH2:62]2)=[CH:59][CH:60]=1

参加物

7

実験手順

2-(tert-Butoxycarbonyl)isoindoline-5-carboxylic acid (0.5 g, 0.0019 mol) ([CAS: 149353-71-9] available commercially from Milestone, for example), O-(1H-benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (0.6 g, 0.0019 mol) and 1-hydroxybenzotriazole hydrate (0.26 g, 0.0019 mol) were dissolved in tetrahydrofuran, under protecting gas, and stirred for 30 min at RT. A solution of 3-(pyridin-4-yl)-3,9-diazaspiro[5.5]undecane dihydrochloride (F-09) (0.5 g, 0.0019 mol) and diisopropylethylamine (DIPEA) (0.86 g, 0.066 mol) in tetrahydrofuran was added, and the reaction mixture was stirred for 15 h at RT. Tetrahydrofuran was then removed in vacuo, the residue was taken up in ethyl acetate and sat. sodium hydrogen carbonate solution, and the phases were separated. The aqueous phase was extracted with ethyl acetate and the combined organic phases were in turn washed with sat. sodium chloride solution, dried over sodium sulfate and concentrated in vacuo. The crude product was purified by column chromatography (ethyl acetate/methanol 10:1+1% ammonia solution (25% aq.)). Yield: 0.85 g (94%)

後処理

  1. stirringthe reaction mixture was stirred for 15 h at RT
  2. customTetrahydrofuran was then removed in vacuo
  3. customsat. sodium hydrogen carbonate solution, and the phases were separated
  4. extractionThe aqueous phase was extracted with ethyl acetate
  5. washwashed with sat. sodium chloride solution
  6. dry with materialdried over sodium sulfate
  7. concentrationconcentrated in vacuo
  8. customThe crude product was purified by column chromatography (ethyl acetate/methanol 10:1+1% ammonia solution (25% aq.))

出典と根拠

ORDレコード
ord-d2c55a0fbad74c79a941b6797d505c6a
出典データセット
uspto-grants-2013_01
特許番号
US08357717B2

反応ノート

読み込み中…